Ghiso E - Search Results

1

MicroRNAs impair MET-mediated invasive growth.

Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S. Migliore C, et al. Among authors: ghiso e. Cancer Res. 2008 Dec 15;68(24):10128-36. doi: 10.1158/0008-5472.CAN-08-2148. Cancer Res. 2008. PMID: 19074879

2

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.

Corso S, Ghiso E, Cepero V, Sierra JR, Migliore C, Bertotti A, Trusolino L, Comoglio PM, Giordano S. Corso S, et al. Among authors: ghiso e. Mol Cancer. 2010 May 26;9:121. doi: 10.1186/1476-4598-9-121. Mol Cancer. 2010. PMID: 20500904 Free PMC article.

3

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.

Cepero V, Sierra JR, Corso S, Ghiso E, Casorzo L, Perera T, Comoglio PM, Giordano S. Cepero V, et al. Among authors: ghiso e. Cancer Res. 2010 Oct 1;70(19):7580-90. doi: 10.1158/0008-5472.CAN-10-0436. Epub 2010 Sep 14. Cancer Res. 2010. PMID: 20841479 Free article.

4

Targeting MET: why, where and how?

Ghiso E, Giordano S. Ghiso E, et al. Curr Opin Pharmacol. 2013 Aug;13(4):511-8. doi: 10.1016/j.coph.2013.05.018. Epub 2013 Jun 21. Curr Opin Pharmacol. 2013. PMID: 23797036 Review.

5

Silencing the MET oncogene leads to regression of experimental tumors and metastases.

Corso S, Migliore C, Ghiso E, De Rosa G, Comoglio PM, Giordano S. Corso S, et al. Among authors: ghiso e. Oncogene. 2008 Jan 24;27(5):684-93. doi: 10.1038/sj.onc.1210697. Epub 2007 Aug 6. Oncogene. 2008. PMID: 17684486

6

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC.

Ghiso E, Migliore C, Ciciriello V, Morando E, Petrelli A, Corso S, De Luca E, Gatti G, Volante M, Giordano S. Ghiso E, et al. Neoplasia. 2017 Dec;19(12):1012-1021. doi: 10.1016/j.neo.2017.10.003. Epub 2017 Nov 11. Neoplasia. 2017. PMID: 29136529 Free PMC article.

7

miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.

Migliore C, Morando E, Ghiso E, Anastasi S, Leoni VP, Apicella M, Cora' D, Sapino A, Pietrantonio F, De Braud F, Columbano A, Segatto O, Giordano S. Migliore C, et al. Among authors: ghiso e. EMBO Mol Med. 2018 Sep;10(9):e8746. doi: 10.15252/emmm.201708746. EMBO Mol Med. 2018. PMID: 30021798 Free PMC article.

8

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S. Petrelli A, et al. Among authors: ghiso e. Oncogene. 2012 Oct 18;31(42):4517-26. doi: 10.1038/onc.2011.631. Epub 2012 Jan 16. Oncogene. 2012. PMID: 22249248 Free article.

9

YAP activation is an early event and a potential therapeutic target in liver cancer development.

Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, Raschioni C, Testore E, Roncalli M, Giordano S, Columbano A. Perra A, et al. Among authors: ghiso e. J Hepatol. 2014 Nov;61(5):1088-96. doi: 10.1016/j.jhep.2014.06.033. Epub 2014 Jul 7. J Hepatol. 2014. PMID: 25010260 Free article.

10

Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3.

Leoni VP, Ledda-Columbano GM, Pibiri M, Saliba C, Perra A, Kowalik MA, Grober OM, Ravo M, Weisz A, Locker J, Ghiso E, Giordano S, Columbano A. Leoni VP, et al. Among authors: ghiso e. J Hepatol. 2011 Nov;55(5):1069-78. doi: 10.1016/j.jhep.2011.02.016. Epub 2011 Feb 25. J Hepatol. 2011. PMID: 21354444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page